iRhythm Technologies (IRTC) Stock Price, News & Analysis

Company Overview

iRhythm Technologies, Inc. is a digital health company focused on the diagnosis and management of cardiac arrhythmias. The company provides ambulatory cardiac monitoring services that enable physicians to evaluate patients for conditions such as atrial fibrillation and other irregular heart rhythms.

Its principal offering is the Zio platform, which combines wearable electrocardiogram (ECG) monitoring devices with cloud-based data analysis and physician reports. Products in the platform include the Zio XT, an extended-wear monitor, and the Zio AT, which provides near-real-time monitoring capabilities. iRhythm also develops software and artificial intelligence tools designed to help analyze cardiac data and support clinical decision-making.

Founded in 2006 and headquartered in San Francisco, iRhythm serves healthcare providers and patients primarily in the United States, with operations and commercial availability also extending to the United Kingdom. The company became publicly traded on the Nasdaq in 2016. Quentin Blackford has served as iRhythm’s president and chief executive officer since 2021.

Key Stats

• Today's Range: $86.30 to $112.95
• 50-Day Range: $90.22 to $134.00
• 52-Week Range: $86.30 to $192.47
• Volume: 5.67 million shs
• Average Volume: 508,477 shs
• Market Capitalization: $2.97 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $171.07
• Consensus Rating: Moderate Buy

iRhythm Technologies Stock Analysis - MarketRank™

iRhythm Technologies scored higher than 68% of companies evaluated by MarketBeat, and ranked 131st out of 886 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

iRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 2 strong buy ratings, 12 buy ratings, 2 hold ratings, and 1 sell rating.

Upside Potential

iRhythm Technologies has a consensus price target of $171.07, representing about 89.6% upside from its current price of $90.22.

Amount of Analyst Coverage

iRhythm Technologies has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 153.70%

Earnings Growth

Earnings for iRhythm Technologies are expected to grow by 153.70% in the coming year, from $0.54 to $1.37 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of iRhythm Technologies is -77.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of iRhythm Technologies is -77.11, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

iRhythm Technologies has a P/B Ratio of 19.03. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.49% of the float of iRhythm Technologies has been sold short.

Short Interest Ratio / Days to Cover

iRhythm Technologies has a short interest ratio ("days to cover") of 6.77.

Change versus previous month

Short interest in iRhythm Technologies has recently increased by 2.07%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

iRhythm Technologies does not currently pay a dividend.

Dividend Growth

iRhythm Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: -0.03

News Sentiment

iRhythm Technologies has a news sentiment score of -0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 28 news articles for iRhythm Technologies this week, compared to 4 articles on an average week.

Search Interest

5 people have searched for IRTC on MarketBeat in the last 30 days.

MarketBeat Follows

3 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, iRhythm Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.98% of the stock of iRhythm Technologies is held by insiders.

Percentage Held by Institutions

iRhythm Technologies has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 11/05/2026
• Today: 11/07/2026
• Jefferies Global Healthcare Conference: 11/19/2026
• 9th Annual Evercore ISI HealthCONx Conference: 12/01/2026
• Citi Annual Global Healthcare Conference 2026: 12/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:IRTC
• CIK: 1388658
• Web: www.irhythmtech.com
• Phone: (415) 632-5700
• Fax: N/A
• Employees: 2,400
• Year Founded: 2006

Price Target and Rating

• Average Price Target for iRhythm Technologies: $171.07
• High Price Target: $210.00
• Low Price Target: $124.00
• Potential Upside/Downside: +89.6%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.88
• Research Coverage: 17 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.43)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 65.85
• P/E Growth: N/A
• Net Income: -$44.55 million
• Net Margins: -1.69%
• Pretax Margin: -1.57%
• Return on Equity: 10.11%
• Return on Assets: 1.53%

Debt

• Debt-to-Equity Ratio: 3.50
• Current Ratio: 3.86
• Quick Ratio: 3.74

Sales & Book Value

• Annual Sales: $747.14 million
• Price / Sales: 3.98
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.74 per share
• Price / Book: 19.03

Miscellaneous

• Outstanding Shares: 32,960,000
• Free Float: 32,640,000
• Market Cap: $2.97 billion
• Optionable: Optionable
• Beta: 1.39